Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the

  MUMBAI (Maharashtra) [India]/ Lexington [Kentucky], Jan 20: Sun Pharmaceutical Industries Limited (Reuters: SUN.BO ) (Bloomberg: SUNP IN) (NSE: SUNPHARMA) (BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) (“Concert”) today announced that they have executed a definitive agreement under which Sun Pharma will acquire all outstanding shares of Concert through a tender offer for an upfront payment of USD 8.00 per share of common stock in cash, or USD 576 million […]

Related Keywords

India , United States , Mumbai , Maharashtra , Washington , America , Sun Pharma , Roger Tung , Janet Metz , Abhishek Sharma , Abhay Gandhi , Justine Koenigsberg , Gaurav Chugh , Concert Pharmaceuticals , Twitter , Sun Pharmaceutical Industries Limited Reuters , Sun Pharmaceutical Industries Ltd , Nasdaq , Foliage Merger Sub Inc , Moelis Company , Chestnut Partners Inc , Concert Investor Relations Department , Health Partners , Drug Administration , Davis Polk Wardwell , Exchange Commission , Sun Pharma Investor Relations Department , Concert Pharmaceuticals Inc , Goodwin Procter , Sun Pharmaceutical Industries Limited , Adds Deuruxolitinib , Potential Best In Class Oral , Alopecia Areata , Autoimmune Dermatological , Global Infrastructure , Provide Broad Access , Global Dermatology Franchise , Late Stage Product , Significant Unmet , Commence Tender Offer , Acquire All Outstanding Shares , Common Stock , Upfront Cash Payment , Equity Consideration , Contingent Value Right , Certain Time Based Net Sales , North America , New Drug Application , Concert Board , Davis Polk , Chestnut Partners , Sun Pharmaceutical Industries , Foliage Merger Sub , Tender Offer Statement , Recommendation Statement , Investor Relations Department , Tender Offer , Large Cross Sectional Survey Study , Investigational Dermatology , Cosmet Investig ,